175 related articles for article (PubMed ID: 24042734)
1. Protooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivo.
Hashimoto M; Suizu F; Tokuyama W; Noguchi H; Hirata N; Matsuda-Lennikov M; Edamura T; Masuzawa M; Gotoh N; Tanaka S; Noguchi M
Oncogenesis; 2013 Sep; 2(9):e70. PubMed ID: 24042734
[TBL] [Abstract][Full Text] [Related]
2. The protooncogene TCL1 is an Akt kinase coactivator.
Laine J; Künstle G; Obata T; Sha M; Noguchi M
Mol Cell; 2000 Aug; 6(2):395-407. PubMed ID: 10983986
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family.
Laine J; Künstle G; Obata T; Noguchi M
J Biol Chem; 2002 Feb; 277(5):3743-51. PubMed ID: 11707444
[TBL] [Abstract][Full Text] [Related]
4. The role of TCL1 in human T-cell leukemia.
Pekarsky Y; Hallas C; Croce CM
Oncogene; 2001 Sep; 20(40):5638-43. PubMed ID: 11607815
[TBL] [Abstract][Full Text] [Related]
5. Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1.
Künstle G; Laine J; Pierron G; Kagami Si S; Nakajima H; Hoh F; Roumestand C; Stern MH; Noguchi M
Mol Cell Biol; 2002 Mar; 22(5):1513-25. PubMed ID: 11839817
[TBL] [Abstract][Full Text] [Related]
6. Genomic analysis of human and mouse TCL1 loci reveals a complex of tightly clustered genes.
Hallas C; Pekarsky Y; Itoyama T; Varnum J; Bichi R; Rothstein JL; Croce CM
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14418-23. PubMed ID: 10588720
[TBL] [Abstract][Full Text] [Related]
7. Identification of nerve growth factor-responsive element of the TCL1 promoter as a novel negative regulatory element.
Hiromura M; Suizu F; Narita M; Kinowaki K; Noguchi M
J Biol Chem; 2006 Sep; 281(38):27753-64. PubMed ID: 16835233
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Akt kinase activity by a peptide spanning the betaA strand of the proto-oncogene TCL1.
Hiromura M; Okada F; Obata T; Auguin D; Shibata T; Roumestand C; Noguchi M
J Biol Chem; 2004 Dec; 279(51):53407-18. PubMed ID: 15459205
[TBL] [Abstract][Full Text] [Related]
9. Targeting mature T cell leukemia: new understanding of molecular pathways.
Pekarsky Y; Hallas C; Croce CM
Am J Pharmacogenomics; 2003; 3(1):31-6. PubMed ID: 12562214
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of mature T-cell leukemia.
Pekarsky Y; Hallas C; Croce CM
JAMA; 2001 Nov; 286(18):2308-14. PubMed ID: 11710897
[TBL] [Abstract][Full Text] [Related]
11. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.
Herling M; Patel KA; Teitell MA; Konopleva M; Ravandi F; Kobayashi R; Jones D
Blood; 2008 Jan; 111(1):328-37. PubMed ID: 17890451
[TBL] [Abstract][Full Text] [Related]
12. A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane.
French SW; Shen RR; Koh PJ; Malone CS; Mallick P; Teitell MA
Biochemistry; 2002 May; 41(20):6376-82. PubMed ID: 12009899
[TBL] [Abstract][Full Text] [Related]
13. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
Sun S; Fang W
Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
[TBL] [Abstract][Full Text] [Related]
14. Subcellular localization of activated AKT in estrogen receptor- and progesterone receptor-expressing breast cancers: potential clinical implications.
Badve S; Collins NR; Bhat-Nakshatri P; Turbin D; Leung S; Thorat M; Dunn SE; Geistlinger TR; Carroll JS; Brown M; Bose S; Teitell MA; Nakshatri H
Am J Pathol; 2010 May; 176(5):2139-49. PubMed ID: 20228224
[TBL] [Abstract][Full Text] [Related]
15. Proto-oncogene TCL1: more than just a coactivator for Akt.
Noguchi M; Ropars V; Roumestand C; Suizu F
FASEB J; 2007 Aug; 21(10):2273-84. PubMed ID: 17360849
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes.
Pekarsky Y; Hallas C; Isobe M; Russo G; Croce CM
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2949-51. PubMed ID: 10077617
[TBL] [Abstract][Full Text] [Related]
17. T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
Bresin A; Ragone G; Cristofoletti C; Arcelli D; Bassi C; Caprini E; Fiorenza MT; Helmer Citterich M; Russo G; Narducci MG
PLoS One; 2018; 13(10):e0204775. PubMed ID: 30286151
[TBL] [Abstract][Full Text] [Related]
18. Deregulated expression of TCL1 causes T cell leukemia in mice.
Virgilio L; Lazzeri C; Bichi R; Nibu K; Narducci MG; Russo G; Rothstein JL; Croce CM
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3885-9. PubMed ID: 9520462
[TBL] [Abstract][Full Text] [Related]
19. Expression of TCL1 in hematologic disorders.
Roos J; Hennig I; Schwaller J; Zbären J; Dummer R; Burg G; Tobler A; Virgilio L; Croce CM; Fey MF; Borisch B
Pathobiology; 2001; 69(2):59-66. PubMed ID: 11752899
[TBL] [Abstract][Full Text] [Related]
20. The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways.
Despouy G; Joiner M; Le Toriellec E; Weil R; Stern MH
Blood; 2007 Dec; 110(13):4406-16. PubMed ID: 17846228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
